• Antimalarial Medicine Quinine Dihydrochloride Injection 600mg 2ml Shinepharm
  • Antimalarial Medicine Quinine Dihydrochloride Injection 600mg 2ml Shinepharm
  • Antimalarial Medicine Quinine Dihydrochloride Injection 600mg 2ml Shinepharm
  • Antimalarial Medicine Quinine Dihydrochloride Injection 600mg 2ml Shinepharm
  • Antimalarial Medicine Quinine Dihydrochloride Injection 600mg 2ml Shinepharm
  • Antimalarial Medicine Quinine Dihydrochloride Injection 600mg 2ml Shinepharm

Antimalarial Medicine Quinine Dihydrochloride Injection 600mg 2ml Shinepharm

Application: Internal Medicine
Usage Mode: Injection
Suitable for: Elderly, Children, Adult
State: Liquid
Shape: Injection
Type: Generic Medicines
Samples:
US$ 0/Piece 1 Piece(Min.Order)
| Request Sample
Customization:

360° Virtual Tour

Diamond Member Since 2015

Suppliers with verified business licenses

Manufacturer/Factory, Trading Company

Basic Info.

Model NO.
AMC14021-02
Pharmaceutical Technology
Chemical Synthesis
Function
Antimalarial
Standard Available
Bp, Cp
Delivery Time
30~60 Days
OEM/ODM
Support
Transport Package
Carton
Specification
600mg 2ml
Trademark
Shinepharm
Origin
China
HS Code
3004909099
Production Capacity
1000000 Boxes/Month

Product Description

Antimalarial Medicine Quinine Dihydrochloride Injection 600mg 2ml Shinepharm

Indications:
Quinine Dihydrochloride injection is indicated for the acute treatment of malaria. It may also be used in the treatment of Babesiosis in conjunction with clindamycin.
Dosage and Administration:
Child and adult:
Loading dose: 20 mg/kg administered over 4 hours, then keep the vein open with an infusion of 5% glucose over 4 hours
Maintenance dose: 8 hours after the start of the loading dose, 10 mg/kg every 8 hours (alternate quinine over 4 hours and 5% glucose over 4 hours)
For adults, administer each dose of quinine in 250 ml. For children under 20 kg, administer each dose of quinine in a volume of 10 ml/kg.
Do not administer a loading dose to patients who have received oral quinine or mefloquine within the previous 24 hours: start with maintenance dose.
Duration
Treat parenterally for at least 24 hours, then, if the patient can tolerate the oral route, change to a complete 3-day course of an artemisinin-based combination (or if not available oral quinine to complete 7 days of quinine treatment). If not, continue parenteral treatment until the patient can change to oral route (without exceeding 7 days of parenteral treatment).

Precautions & Warning:
Check for hypersensitivity to quinine or quinidine BEFORE administration. It is important that when given intravenously it should be given by SLOW infusion and the patient observed closely for signs of cardiotoxicity.
The half-life of quinine is prolonged in hepatitis and moderate chronic liver disease.
These symptoms should also be monitored during treatment:
Haemolysis
Prothrombin formation
Atrial fibrillation
Hypersensitivity

Storage instructions:
Store below 25°C and protect from light

Antimalarial Medicine Quinine Dihydrochloride Injection 600mg 2ml ShinepharmAntimalarial Medicine Quinine Dihydrochloride Injection 600mg 2ml Shinepharm
Antimalarial Medicine Quinine Dihydrochloride Injection 600mg 2ml ShinepharmAntimalarial Medicine Quinine Dihydrochloride Injection 600mg 2ml ShinepharmAntimalarial Medicine Quinine Dihydrochloride Injection 600mg 2ml ShinepharmAntimalarial Medicine Quinine Dihydrochloride Injection 600mg 2ml Shinepharm

 

Send your message to this supplier

*From:
*To:
*Message:

Enter between 20 to 4,000 characters.

This is not what you are looking for? Post a Sourcing Request Now

You Might Also Like

360° Virtual Tour

Diamond Member Since 2015

Suppliers with verified business licenses

Manufacturer/Factory, Trading Company
Management System Certification
ISO 9001, GMP, ISO 13485, FSC
Import & Export Mode
Have Own Export License